LAI PrEP: Addressing the How To’s of Evidence-Based Practice & Guideline Adoption
Join the CHCANYS HIV/Hep C/STI Sub-committee for a series of engaging virtual discussions on updates made to the evidence-based guidelines pertaining to long- acting injectable (LAI) Pre-exposure prophylaxis (PrEP) medication lenacapavir/YEZTUGO, and operationalizing LAI PrEP using innovative, patient-centered clinical care pathways.
Guest speakers include Aviva Cantor, Clinical Director of HIV Services with Callen-Lorde Community Health Center, and Dr. Carolyn Chu, Professor of Family Community Medicine, and Dr. Cristina Gruta, HIV Pharmacist Specialist at the University of California, San Francisco and clinician education specialist with the National Clinician Consultation Center (NCCC).
Register here for our first session on January 23rd at noon!
For questions related to this session, and to learn more about the HIV/Hep C/STI Sub-committee, contact Meital Fried-Almog at malmog@chcanys.org.